Immune check‐point inhibitor‐related pneumonitis: acute lung injury with rapid progression and organising pneumonia with less severe clinical disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune check‐point inhibitor‐related pneumonitis: acute lung injury with rapid progression and organising pneumonia with less severe clinical disease

Published:2022-08-17 Issue:6 Volume:81 Page:724-731
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Imran Saira¹,Golden Andrew²,Feinstein Marc¹,Plodkowski Andrew³,Bodd Francis²,Rekhtman Natasha²,Travis William D²,Stover Diane E¹,Sauter Jennifer L²

Affiliation:

1. Department of Pulmonary Medicine Memorial Sloan Kettering Cancer Center New York NY USA

2. Department of Pathology and Laboratory Medicine Memorial Sloan Kettering Cancer Center New York NY USA

3. Department of Radiology Memorial Sloan Kettering Cancer Center New York NY USA

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/his.14704

Reference25 articles.

1. Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors

2. Immune-Related Adverse Events Associated with Immune Checkpoint Blockade

3. Anti–Programmed Cell Death 1/Ligand 1 (PD-1/PD-L1) Antibodies for the Treatment of Urothelial Carcinoma: State of the Art and Future Development

4. Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

5. Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors and CAR-T Cell Therapy: A Comprehensive Imaging-Based Review;Cancers;2024-07-19

2. Ipilimumab/nivolumab/pembrolizumab;Reactions Weekly;2023-06-10

3. Immune-related pulmonary toxicities of checkpoint inhibitors in non-small cell lung cancer: Diagnosis, mechanism, and treatment strategies;Frontiers in Immunology;2023-04-04

4. Advances in CT features and radiomics of checkpoint inhibitor-related pneumonitis: A short review;Frontiers in Immunology;2023-01-23

5. Nintedanib in an elderly non-small-cell lung cancer patient with severe steroid-refractory checkpoint inhibitor-related pneumonitis: A case report and literature review;Frontiers in Immunology;2023-01-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3